Canadian CANNAINVESTOR Magazine July / August 2018 | Page 293

293

Louis Kyron, CPA, CGA

Editor in Chief

@LouisKyron

CCIM:Piggy backing off of the last question … I am thinking about the non-smoking retirement home. There are movie nights, card nights, and other social events – ideal for beverages and in many such retirement homes cooking in the units tends to be discouraged if not prohibited outright … plus the heating of cannabis in an apartment’s oven could result in strong odour that carries to other units and hallways. Again … I am thinking whether medical or recreational. Do you see the aging population as a large potential market segment?

TGOD: Absolutely, evidence supports cannabis assisting people with countless ailments including sleep disorder, anxiety and chronic pain. The aging population represents an important consumer base that we want to be able to provide premium organic cannabis products to. TGOD aims to provide patients and customers with novel and effective dose-controlled delivery systems that are safer, more standardized, and more discreet than most current cannabinoid delivery systems.

CCIM:To the extent that you can answer … is TGOD done with respect to JVs, partnerships, or even M&A in the beverage space?

TGOD: Absolutely not. Remember, our entire domestic operations are fully funded, we have over $300 million dollars in cash now with a significant portion earmarked to these initiatives. We will continue to look for opportunities that make sense for us, both internationally, and domestically. With the experience our senior executives have in the beverage and beverage alcohol industries (125+ years) coupled with our newly formed beverage division, 40,000 kg productive capacity beverage specific facility, and new hires like Prem Virmani (see press release here) I believe we are in an excellent position to form a multitude of strategic partnerships across the board.

CCIM:Just about out of real estate here and I want to give you the opportunity to remind your current investors as well as prospective investors – why invest in TGOD?

- Largest exchange-traded fund holding: We are recognized as the No. 1 holding in the largest cannabis ETF in the United States;

- Licensing partnerships: U.S. states have become landlocked. We can export intellectual property and license various technologies using our land and our licences to manufacture branded products in Canada, and own the international sales and distribution channels:

- Stillwater's, Ripple SC: soluble cannabinoids;

- Evolab: the No. 1 selling vaporizer in Colorado;

- CBx Sciences: medical and recreational cannabis products,

R&D and cannabis specific IP;

- Launch of strategic beverage science and research division, 40,000 kg annual capacity cultivation facility dedicated to beverage, and appointment of Prem Virmani as beverage science and research division chair. Mr. Virmani is the former senior vice-president of global science and research for Cott Beverages Inc.;

- Developing a beverage platform moving us into much higher margin products for the future. Our team has over 125 years of executive experience in consumer-packaged goods, beverage and beverage alcohol, more than any other company in the industry;

- Cultivation licence: for Valleyfield granted and oils licence for Hamilton granted;

- $25-million bought deal at $6.40;

- Largest initial public offering in cannabis history, raising $132.1-million and listing on the world's premier exchange for cannabis companies, the Toronto Stock Exchange;

- Certified organic product and process by Eco-Cert;

- Focus on executing with excellence.

Imagine what we can accomplish in the future?